ZW25 Active and Well Tolerated Across Multiple HER2-expressing Tumor Types Durable Anti-Tumor Activity with Confirmed Partial ...
ADVFN · 17h
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system. The team discovered that 4-1BB ...
NEWCASTLE, England, Nov. 13, 2018 /PRNewswire/ -- Leica Biosystems, a leading provider of pathology products and solutions, g...
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Zymeworks Inc. (NYSE: ZYME) announced today the plenary presentation of updated ZW25 cli...
Major pharmaceutical companies involved in the development of Antibody-drug Conjugates (ADCs) either outsource the manufacturing of their ADC or are collaborating with a Contract Development Manufactu...
World-wide more than 600 clinical trials with Antibody-drug Conjugates (ADCs) have been or are currently being conducted. Building on their experience, researchers continue to advance these drugs ...
The interaction between antigens and antibodies, also called immunoglobulins, underpins the immune response. Antigens are typ...
HOLON, Israel, Nov. 13, 2018 /PRNewswire/ -- Compugen Ltd. CGEN, -5.71% a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that a patent for COM...
Despite billions of dollars and decades spent on Alzheimer’s research, medical scientists still haven’t found a cure, but a d...
Newsday · 3d
Celldex Presents Emerging MerTK Antibody Program at the Society for Immunotherapy of Cancer's 33rd Annual Meeting Antibody technology provides an exciting new approach to enhance innate immune functio...
Nasdaq · 4d